Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).
Journal: Lancet regional health. Americas
Published: March 25, 2026
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: February 15, 2025
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.
Journal: Frontiers in medicine
Published: January 11, 2025
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.
Journal: Acta haematologica
Published: December 16, 2024
Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis.
Journal: Cancer reports (Hoboken, N.J.)
Published: October 08, 2023
Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
Journal: Leukemia research reports
Published: September 10, 2023
Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Journal: Haematologica
Published: March 23, 2023
Co-management strategies for acute myeloid leukemia patients in the community setting.
Journal: Frontiers in oncology
Published: October 03, 2022
Cancer and COVID-19: analysis of patient outcomes.
Journal: Future oncology (London, England)
Published: July 15, 2021
Last Updated: 09/26/2026